21 February 2013 Combined photothermal therapy and chemotherapy in cancer using HER-2 targeted PLGA nanoparticles
Author Affiliations +
Proceedings Volume 8582, Biophotonics and Immune Responses VIII; 85820B (2013) https://doi.org/10.1117/12.2005500
Event: SPIE BiOS, 2013, San Francisco, California, United States
We previously reported on the synergistic effects of hyperthermia and chemotherapy using doxorubicin (DOX) and Indocyanine Green (ICG). In a previous study we also explored the potential use of simultaneous entrapment of optical/imaging and chemotherapeutic agents into PLGA nanoparticles. The aim of the present study is to further decorate their surface with tumor specific monoclonal antibodies in order to achieve simultaneous therapy and diagnosis in a targeted manner. Thus, ICG was selected as an imaging agent due to its wide clinical applications and since it can also serve as hyperthermia agent. DOX was selected as the chemotherapeutic agent since it is used clinically for a large spectrum of tumors.
© (2013) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Anthony J McGoron, Anthony J McGoron, Supriya Srinivasan, Supriya Srinivasan, Tingjun Lei, Tingjun Lei, Yuan Tang, Yuan Tang, Romila Manchanda, Romila Manchanda, "Combined photothermal therapy and chemotherapy in cancer using HER-2 targeted PLGA nanoparticles", Proc. SPIE 8582, Biophotonics and Immune Responses VIII, 85820B (21 February 2013); doi: 10.1117/12.2005500; https://doi.org/10.1117/12.2005500

Back to Top